Garanzini Michael 4
4 · EYEGATE PHARMACEUTICALS INC · Filed Nov 17, 2017
Insider Transaction Report
Form 4
Garanzini Michael
Chief Commercial Officer
Transactions
- Award
Stock Option (right to buy)
2017-11-17+85,000→ 85,000 totalExercise: $1.09Exp: 2027-11-17→ Common Stock (85,000 underlying)
Footnotes (1)
- [F1]The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on November 1, 2018, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years.